Skip to main content

Table 2 Immunophenotyping of leucocytes by flow cytometry

From: Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency

Immunophenotyping of leucocytes (x103cells/mm3)

Age at diagnosis Y: years/m: months

Lymphocytes CD45+

CD3+

CD3+ CD4+

CD3+ CD8+

CD19+

HLA DR

1

10 y

2.9 (1.90–3.70)

2.6 (1.20–2.60)

0.6 (0.65–1.50)

1.9 (0.37–1.10)

0.2 (0.27–0.86)

0

2

2 y 6 m

4.6 (2.30–5.40)

2.4 (1.40–3.70)

0.5 (0.70–2.20)

1.5 (0.49–1.30)

1.2 (0.39–1.40)

0

3

4 y

6.2 (2.30–5.40)

4.8 (1.40–3.70)

0.3 (0.70–2.20)

2.9 (0.49–1.30)

0.2 (0.39–1.40)

0

4

2 m

3.3 (3.40–7.60)

1.6 (2.50–5.50)

0.4 (1.60–4.00)

1.2 (0.56–1.70)

0.7 (0.30–2.00)

0

5

1 y 10 m

1.2 (3.60–8.90)

0.3 (2.10–6.20)

0.2 (1.30–3.40)

0.1 (0.62–2.00)

0.4 (0.72–2.60)

0

6

4 y

1.5 (2.30–5.40)

0.7 (1.40–3.70)

0.3 (0.70–2.20)

0.3 (0.49–1.30)

0.3 (0.39–1.40)

0

7

2 y 3 m

4 (2.30–5.40)

2.5 (1.40–3.70)

1.4 (0.70–2.20)

0.6 (0.49–1.30)

1.1 (0.39–1.40)

0

8

4 y

3.7 (2.30–5.40)

2.3 (1.40–3.70)

3.3 (0.70–2.20)

1.1 (0.49–1.30)

0.4 (0.39–1.40)

0

9

2 y

1.2 (2.30–5.40)

0.8 (1.40–3.70)

0.2 (0.70–2.20)

0.5 (0.49–1.30)

0.07 (0.39–1.40)

0

10

6 y

3.2 (1.90–3.70)

2.4 (1.20–2.60)

0.3 (0.65–1.50)

1.5 (0.37–1.10)

0.4 (0.27–0.86)

0

11

4 y

3.5 (2.30–5.40)

1.9 (1.40–3.70)

0.15 (0.70–2.20)

1 (0.49–1.30)

0.18 (0.39–1.40)

0

  1. (Normal values for age are given between brackets)[20].